Logo image of CLI.MI

CENTRALE DEL LATTE D'ITALIA (CLI.MI) Stock Fundamental Analysis

BIT:CLI - Euronext Milan - IT0003023980 - Common Stock - Currency: EUR

3.04  0 (0%)

Fundamental Rating

5

Taking everything into account, CLI scores 5 out of 10 in our fundamental rating. CLI was compared to 56 industry peers in the Food Products industry. CLI has a medium profitability rating, but doesn't score so well on its financial health evaluation. A decent growth rate in combination with a cheap valuation! Better keep an eye on CLI.


Dividend Valuation Growth Profitability Health

Quickly go to:

6

1. Profitability

1.1 Basic Checks

In the past year CLI was profitable.
CLI had a positive operating cash flow in the past year.
In the past 5 years CLI has always been profitable.
CLI had a positive operating cash flow in each of the past 5 years.
CLI.MI Yearly Net Income VS EBIT VS OCF VS FCFCLI.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M 30M

1.2 Ratios

CLI's Return On Assets of 3.80% is in line compared to the rest of the industry. CLI outperforms 57.63% of its industry peers.
CLI has a Return On Equity of 14.22%. This is amongst the best in the industry. CLI outperforms 84.75% of its industry peers.
With an excellent Return On Invested Capital value of 11.61%, CLI belongs to the best of the industry, outperforming 93.22% of the companies in the same industry.
CLI had an Average Return On Invested Capital over the past 3 years of 4.02%. This is below the industry average of 6.33%.
The last Return On Invested Capital (11.61%) for CLI is above the 3 year average (4.02%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 3.8%
ROE 14.22%
ROIC 11.61%
ROA(3y)0.98%
ROA(5y)1.12%
ROE(3y)3.7%
ROE(5y)4.3%
ROIC(3y)4.02%
ROIC(5y)3.66%
CLI.MI Yearly ROA, ROE, ROICCLI.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10

1.3 Margins

Looking at the Profit Margin, with a value of 1.88%, CLI is in line with its industry, outperforming 44.07% of the companies in the same industry.
CLI's Profit Margin has improved in the last couple of years.
CLI's Operating Margin of 3.71% is in line compared to the rest of the industry. CLI outperforms 45.76% of its industry peers.
In the last couple of years the Operating Margin of CLI has grown nicely.
The Gross Margin of CLI (19.29%) is worse than 76.27% of its industry peers.
CLI's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 3.71%
PM (TTM) 1.88%
GM 19.29%
OM growth 3Y15.43%
OM growth 5YN/A
PM growth 3Y16.01%
PM growth 5YN/A
GM growth 3Y-0.63%
GM growth 5Y-14.6%
CLI.MI Yearly Profit, Operating, Gross MarginsCLI.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40

More info and screens

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so CLI is creating value.
CLI has about the same amout of shares outstanding than it did 1 year ago.
CLI has about the same amout of shares outstanding than it did 5 years ago.
Compared to 1 year ago, CLI has a worse debt to assets ratio.
CLI.MI Yearly Shares OutstandingCLI.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
CLI.MI Yearly Total Debt VS Total AssetsCLI.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

An Altman-Z score of 2.52 indicates that CLI is not a great score, but indicates only limited risk for bankruptcy at the moment.
CLI's Altman-Z score of 2.52 is fine compared to the rest of the industry. CLI outperforms 64.41% of its industry peers.
The Debt to FCF ratio of CLI is 6.36, which is on the high side as it means it would take CLI, 6.36 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 6.36, CLI is in line with its industry, outperforming 52.54% of the companies in the same industry.
CLI has a Debt/Equity ratio of 0.56. This is a neutral value indicating CLI is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.56, CLI perfoms like the industry average, outperforming 52.54% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.56
Debt/FCF 6.36
Altman-Z 2.52
ROIC/WACC2.43
WACC4.77%
CLI.MI Yearly LT Debt VS Equity VS FCFCLI.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M

2.3 Liquidity

A Current Ratio of 0.86 indicates that CLI may have some problems paying its short term obligations.
CLI's Current ratio of 0.86 is on the low side compared to the rest of the industry. CLI is outperformed by 81.36% of its industry peers.
A Quick Ratio of 0.69 indicates that CLI may have some problems paying its short term obligations.
CLI has a Quick ratio of 0.69. This is in the lower half of the industry: CLI underperforms 69.49% of its industry peers.
Industry RankSector Rank
Current Ratio 0.86
Quick Ratio 0.69
CLI.MI Yearly Current Assets VS Current LiabilitesCLI.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M

More info and screens

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 36.57% over the past year.
Measured over the past years, CLI shows a very strong growth in Earnings Per Share. The EPS has been growing by 24.63% on average per year.
CLI shows a small growth in Revenue. In the last year, the Revenue has grown by 3.88%.
CLI shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 14.83% yearly.
EPS 1Y (TTM)36.57%
EPS 3Y24.63%
EPS 5YN/A
EPS Q2Q%25.9%
Revenue 1Y (TTM)3.88%
Revenue growth 3Y7.26%
Revenue growth 5Y14.83%
Sales Q2Q%-4.76%

3.2 Future

The Earnings Per Share is expected to grow by 15.31% on average over the next years. This is quite good.
The Revenue is expected to grow by 3.36% on average over the next years.
EPS Next Y-2.22%
EPS Next 2Y15.47%
EPS Next 3Y15.31%
EPS Next 5YN/A
Revenue Next Year8.24%
Revenue Next 2Y4.56%
Revenue Next 3Y3.36%
Revenue Next 5YN/A

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CLI.MI Yearly Revenue VS EstimatesCLI.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M
CLI.MI Yearly EPS VS EstimatesCLI.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.2 -0.2 0.4 -0.4 0.6 0.8

More info and screens

8

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 4.16, which indicates a rather cheap valuation of CLI.
Compared to the rest of the industry, the Price/Earnings ratio of CLI indicates a rather cheap valuation: CLI is cheaper than 94.92% of the companies listed in the same industry.
CLI is valuated cheaply when we compare the Price/Earnings ratio to 26.43, which is the current average of the S&P500 Index.
CLI is valuated cheaply with a Price/Forward Earnings ratio of 5.02.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CLI indicates a rather cheap valuation: CLI is cheaper than 98.31% of the companies listed in the same industry.
CLI is valuated cheaply when we compare the Price/Forward Earnings ratio to 22.17, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 4.16
Fwd PE 5.02
CLI.MI Price Earnings VS Forward Price EarningsCLI.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CLI is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
93.22% of the companies in the same industry are more expensive than CLI, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 3.25
EV/EBITDA 2.25
CLI.MI Per share dataCLI.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

The decent profitability rating of CLI may justify a higher PE ratio.
A more expensive valuation may be justified as CLI's earnings are expected to grow with 15.31% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y15.47%
EPS Next 3Y15.31%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for CLI!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CENTRALE DEL LATTE D'ITALIA

BIT:CLI (5/23/2025, 7:00:00 PM)

3.04

0 (0%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.01%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap42.56M
Analysts80
Price Target5.81 (91.12%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)39.02%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-18.52%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)7.16%
Valuation
Industry RankSector Rank
PE 4.16
Fwd PE 5.02
P/S 0.08
P/FCF 3.25
P/OCF 2.59
P/B 0.62
P/tB 0.86
EV/EBITDA 2.25
EPS(TTM)0.73
EY24.01%
EPS(NY)0.61
Fwd EY19.93%
FCF(TTM)0.93
FCFY30.75%
OCF(TTM)1.17
OCFY38.58%
SpS37.15
BVpS4.92
TBVpS3.53
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 3.8%
ROE 14.22%
ROCE 16.47%
ROIC 11.61%
ROICexc 18.89%
ROICexgc 25.91%
OM 3.71%
PM (TTM) 1.88%
GM 19.29%
FCFM 2.52%
ROA(3y)0.98%
ROA(5y)1.12%
ROE(3y)3.7%
ROE(5y)4.3%
ROIC(3y)4.02%
ROIC(5y)3.66%
ROICexc(3y)6.06%
ROICexc(5y)5.59%
ROICexgc(3y)8.01%
ROICexgc(5y)7.3%
ROCE(3y)5.7%
ROCE(5y)5.19%
ROICexcg growth 3Y32.21%
ROICexcg growth 5YN/A
ROICexc growth 3Y30.06%
ROICexc growth 5YN/A
OM growth 3Y15.43%
OM growth 5YN/A
PM growth 3Y16.01%
PM growth 5YN/A
GM growth 3Y-0.63%
GM growth 5Y-14.6%
F-Score7
Asset Turnover2.02
Health
Industry RankSector Rank
Debt/Equity 0.56
Debt/FCF 6.36
Debt/EBITDA 1.11
Cap/Depr 21.57%
Cap/Sales 0.64%
Interest Coverage 5.89
Cash Conversion 47.24%
Profit Quality 133.55%
Current Ratio 0.86
Quick Ratio 0.69
Altman-Z 2.52
F-Score7
WACC4.77%
ROIC/WACC2.43
Cap/Depr(3y)17.55%
Cap/Depr(5y)36.42%
Cap/Sales(3y)0.86%
Cap/Sales(5y)2.07%
Profit Quality(3y)1366.96%
Profit Quality(5y)1110.01%
High Growth Momentum
Growth
EPS 1Y (TTM)36.57%
EPS 3Y24.63%
EPS 5YN/A
EPS Q2Q%25.9%
EPS Next Y-2.22%
EPS Next 2Y15.47%
EPS Next 3Y15.31%
EPS Next 5YN/A
Revenue 1Y (TTM)3.88%
Revenue growth 3Y7.26%
Revenue growth 5Y14.83%
Sales Q2Q%-4.76%
Revenue Next Year8.24%
Revenue Next 2Y4.56%
Revenue Next 3Y3.36%
Revenue Next 5YN/A
EBIT growth 1Y17.84%
EBIT growth 3Y23.81%
EBIT growth 5YN/A
EBIT Next Year133.78%
EBIT Next 3Y38.93%
EBIT Next 5YN/A
FCF growth 1Y-62.61%
FCF growth 3Y-17.37%
FCF growth 5YN/A
OCF growth 1Y-55.87%
OCF growth 3Y-18.49%
OCF growth 5Y10.4%